Sargramostim Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 250 mcg/5 mL
Reference Brands: Leukine (USA/EU)
Category:
Critical Care
Sargramostim is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) used to stimulate the production of white blood cells. It is prescribed to patients undergoing bone marrow transplantation, chemotherapy, or with severe neutropenia to reduce infection risk. Administered via subcutaneous or intravenous injection, sargramostim helps accelerate bone marrow recovery and improve immune function.
Sargramostim is available in Injection
and strengths such as 250 mcg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Sargramostim is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Sargramostim can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing